Correlation Between Medesis Pharma and Abionyx Pharma

Can any of the company-specific risk be diversified away by investing in both Medesis Pharma and Abionyx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medesis Pharma and Abionyx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Medesis Pharma SA and Abionyx Pharma SA, you can compare the effects of market volatilities on Medesis Pharma and Abionyx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medesis Pharma with a short position of Abionyx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medesis Pharma and Abionyx Pharma.

Diversification Opportunities for Medesis Pharma and Abionyx Pharma

0.26

Correlation Coefficient

Medesis Pharma  Abionyx Pharma

Modest diversification

The 3 months correlation between Medesis and Abionyx is 0.26. Overlapping area represents the amount of risk that can be diversified away by holding Medesis Pharma SA and Abionyx Pharma SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Abionyx Pharma SA and Medesis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medesis Pharma SA are associated (or correlated) with Abionyx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Abionyx Pharma SA has no effect on the direction of Medesis Pharma i.e., Medesis Pharma and Abionyx Pharma go up and down completely randomly.

Pair Corralation between Medesis Pharma and Abionyx Pharma

Assuming the 90 days trading horizon Medesis Pharma SA is expected to generate 1.18 times more return on investment than Abionyx Pharma. However, Medesis Pharma is 1.18 times more volatile than Abionyx Pharma SA. It trades about -0.04 of its potential returns per unit of risk. Abionyx Pharma SA is currently generating about -0.13 per unit of risk. If you would invest  34.00  in Medesis Pharma SA on October 3, 2024 and sell it today you would lose (1.00) from holding Medesis Pharma SA or give up 2.94% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Medesis Pharma SA  vs.  Abionyx Pharma SA

Medesis Pharma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Medesis Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors.

Abionyx Pharma SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Abionyx Pharma SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Abionyx Pharma is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Medesis Pharma and Abionyx Pharma

The main advantage of trading using opposite Medesis Pharma and Abionyx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medesis Pharma position performs unexpectedly, Abionyx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Abionyx Pharma will offset losses from the drop in Abionyx Pharma's long position.

The idea behind Medesis Pharma SA and Abionyx Pharma SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.